News for Olaplex Shareholders: Johnson Fistula encourages OLPX shareholders

News for Olaplex Shareholders: Johnson Fistula encourages OLPX shareholders


SAN DIEGO, Oct. 18, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistel, LLP ( examines whether Olaplex Holdings, Inc. (“Olaplex” or the “Company”) OLPX, one of its officers or others has violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they can be recovered under federal securities laws.

What if I bought Olaplex common stock? If you bought Olaplex common stock and suffered significant losses on your investment, join our investigation now:

Click or paste the following web address into your browser to submit your losses:

Or contact Jim Baker at for more information [email protected] or (619) 814-4471

There are no costs or obligations for you.

What does Johnson examine fistula? In September 2021, Olaplex completed its initial public offering (“IPO”) and the Company sold 73.7 million shares at $21.00 per share. Since the IPO, the stock has plummeted, closing at $9.60 on October 17, 2022. On October 18, 2022, the company lowered its guidance for fiscal year 2022. Following this news, the stock price fell 38% on October 18, 2022 – hourly trading.

What if I have relevant non-public information? Individuals with nonpublic information about the Company should consider assisting our investigation or participating in the SEC Whistleblower Program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to 30% for each successful recovery by the SEC. For more information, contact Jim Baker at (619) 814-4471 or [email protected].

Johnson Fistula, LLP
Jim Baker, Senior Securities Analyst
Phone: (619) 814-4471
E-mail: [email protected]

Read full story here

More to explorer